Ekso Bionics Holdings, Inc. (EKSO)
| Market Cap | 23.38M |
| Revenue (ttm) | 11.90M |
| Net Income (ttm) | -10.71M |
| Shares Out | 12.84M |
| EPS (ttm) | -0.93 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11,695 |
| Open | 1.85 |
| Previous Close | 1.80 |
| Day's Range | 1.81 - 1.86 |
| 52-Week Range | 1.54 - 6.10 |
| Beta | 1.94 |
| Analysts | Buy |
| Price Target | 11.22 (+516.5%) |
| Earnings Date | Apr 28, 2022 |
About EKSO
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provide...
Financial Performance
In 2021, EKSO's revenue was $11.25 million, an increase of 26.62% compared to the previous year's $8.88 million. Losses were -$9.76 million, -38.30% less than in 2020.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for EKSO stock is "Buy." The 12-month stock price forecast is 11.22, which is an increase of 516.48% from the latest price.
News
Ekso Bionics (EKSO) Could Find Support Soon, Here's Why You Should Buy the Stock Now
Ekso Bionics (EKSO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wal...
Ekso Bionics (EKSO) Reports Q1 Loss, Lags Revenue Estimates
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 12.20% and 19.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Ekso Bionics Reports First Quarter 2022 Results
RICHMOND, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today report...
Ekso Bionics to Report First Quarter 2022 Financial Results on April 28
RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announ...
Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 8% and 1.90%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Ekso Bionics to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
RICHMOND, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announc...
Ekso Bionics Announces Leadership Transition
Board Member Steven Sherman to be Appointed CEO
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results
Company Achieves Record Quarterly Revenue of $3.9 million to $4.1 million 1
Ekso Bionics to Participate at the H.C. Wainwright BioConnect Virtual Conference
RICHMOND, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that manageme...
Ekso Bionics Appoints Corinna E. Lathan, Ph.D.
RICHMOND, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announc...
Ekso Bionics Announces EksoNR Multi-Unit Order by Nebraska Fraternal Order of Eagles
- Foundation Donates Units to Two Inpatient Rehabilitation Facilities in Nebraska -
Ekso Bionics (EKSO) Reports Q3 Loss, Tops Revenue Estimates
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 32.00% and 18.18%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Ekso Bionics Reports Third Quarter 2021 Results
RICHMOND, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reporte...
Ekso Bionics to Report Third Quarter 2021 Financial Results on November 2, 2021
RICHMOND, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announc...
Ekso Bionics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference
RICHMOND, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that managem...
Ekso Bionics (EKSO) Reports Q2 Loss, Tops Revenue Estimates
Ekso Bionics (EKSO) delivered earnings and revenue surprises of -4.00% and 3.32%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Ekso Bionics Reports Second Quarter 2021 Results
RICHMOND, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reporte...
Will Ekso Bionics (EKSO) Report Negative Q2 Earnings? What You Should Know
Ekso Bionics (EKSO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for May 27th
AFYA, BNL, CLBS, EKSO, and LLY have been added to the Zacks Rank #5 (Strong Sell) List on May 27, 2021
Moving Average Crossover Alert: Ekso Bionics (EKSO)
Ekso Bionics (EKSO) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Ekso Bionics Holdings: Q1 Earnings Insights
Shares of Ekso Bionics Holdings (NASDAQ:EKSO) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 22.73% year over year to ($0.34), which m...
Ekso Bionics Reports First Quarter 2021 Results
RICHMOND, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today report...
Will Ekso Bionics (EKSO) Report Negative Q1 Earnings? What You Should Know
Ekso Bionics (EKSO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ekso Bionics to Report First Quarter 2021 Financial Results on April 29, 2021
RICHMOND, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will...
Ekso Bionics (EKSO) Surges 9.4%: Is This an Indication of Further Gains?
Ekso Bionics (EKSO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ...